Minnesota · 2025-2026 Regular Session · Bill

HF 4064: Commissioner of health directed to study and report on activities to support innovations in cell and gene therapy to treat rare diseases, report required, and money appropriated.

In committee Last action April 20, 2026: Author added Torkelson

Plain-language summary

HF 4064 is a bill introduced in the Minnesota House on March 9, 2026. According to its official title, it concerns: Commissioner of health directed to study and report on activities to support innovations in cell and gene therapy to treat rare diseases, report required, and money appropriated. Primary sponsor: Liz Reyer (Democratic-Farmer-Labor). It lists 9 additional sponsors. Most recent recorded action (April 20, 2026): Author added Torkelson.

Sponsors

Primary sponsor: Liz Reyer (Democratic-Farmer-Labor). 9 co-sponsors.